HOME site map Contact Us 2015/10/09 Maxacalcitol Ointment 25 μg / g "Takata" Sales Resumption Information 2015/08/25 The 17th health information "Healthy Navi" was published in the Nihon Keizai Shimbun. 2015/07/30 Recruitment information update (mid-career recruitment) 2015/07/16 Published the 16th health information "Healthy Navi" in the Nihon Keizai Shimbun 2015/07/08 Recruitment information update (mid-career recruitment) 2015/06/19 New release information 2015/06/19 Published the 15th health information "Healthy Navi" in the Nihon Keizai Shimbun 2015/06/18 Press Release "Notice of Supplementary Listing and New Release of 11 Items of 4 Ingredients of Generic Drugs" 2015/05/12 Published the 14th health information "Healthy Navi" in the Nihon Keizai Shimbun 2015/04/15 Recruitment information update (mid-career recruitment) 2015/04/08 Published the 13th health information "Healthy Navi" in the Nihon Keizai Shimbun 2015/04/01 Shionogi Pharmaceutical Co., Ltd. Sales transfer product: [Mikocist] Information on packaging changes 2015/04/01 Shionogi Pharmaceutical Co., Ltd. Sales transfer product: [Reminaron] Information on packaging changes 2015/03/06 Information on products scheduled to be listed in June 2015 2015/02/25 Maxacalcitol Ointment 25 μg / g "Takata" Discontinuation Information 2015/02/16 Notice of acquisition of manufacturing and marketing approval 2015/01/16 Recruitment information update (mid-career recruitment) 2014/12/26 Sales Transfer Information-Reminaron Injection 100mg / 500mg, Mycocyst Intravenous Solution 0.1% / 0.2% 2014/12/12 New release information 2014/12/01 Press Release "Notice Concerning Succession and Sales Transfer of" Celestamine "and" Polaramine "" 2014/12/01 MSD Co., Ltd. Succession / Sales Transferred Items: [Polaramin] Information on packaging changes 2014/12/01 MSD Co., Ltd. Successor product: [Celestamin] Information on packaging changes 2014/11/28 Product information scheduled to be listed in December 2014 (Olopatadine hydrochloride granules 0.5% "Takata" sales canceled) 2014/11/27 Company profile update (sales, number of employees) 2014/11/27 Company profile update (history) 2014/11/12 Recruitment information update (mid-career recruitment) 2014/10/22 Notice of establishment of free call supermarket at "Inquiry window for drug information" 2014/10/06 Recruitment information update (mid-career recruitment) 2014/10/02 Press release "Notice of additional approval for imatinib tablet 100 mg" Yakult "indications, dosage and administration" 2014/09/05 Recruitment information update (mid-career recruitment) 2014/08/15 Press Release "Notice of Acquisition of Manufacturing and Marketing Approval for 4 Ingredients and 5 Items of Generic Drugs" 2014/08/15 Press release "Notice of acquisition of manufacturing and marketing approval for imatinib tablets 200 mg" Yakult "" 2014/08/01 Recruitment information update (mid-career recruitment) 2014/07/10 Recruitment information update (mid-career recruitment) 2014/06/20 Press release "Notice of supplementary listing and new release of 8 items of 4 generic drugs" 2014/06/20 New release information 2014/06/16 "Takata Seiyaku's Challenge" published in Nihon Keizai Shimbun 6/16 2014/06/06 Recruitment information update (mid-career recruitment) 2014/05/16 Press Release "Notice of Completion of Satte Factory" 2014/04/24 Published the 12th health information "Healthy Navi" in the Nihon Keizai Shimbun Information published in Nihon Keizai Shimbun 1st Acute Otitis Media (Posted in June 2013) 2nd heat rash (published in July 2013) The 3rd athlete's foot (published in July 2013) 4th Heat Stroke (Posted in August 2013) 5th Sleep Disorder (Posted in September 2013) 6th Cough (Posted in October 2013) The 7th Influenza (Posted in November 2013) 8th Gastritis (Posted in December 2013) 9th New Year fat (published in January 2014) The 10th pollinosis (published in February 2014) 11th Hypertension (Posted in March 2014) 12th Muscle Pain (Posted in April 2014) 13th Health Examination (Posted in April 2015) 14th Depression Prevention (Posted in May 2015) The 15th Prevention of Caries (Posted in June 2015) 16th Conjunctivitis (Posted in July 2015) 17th Heat Stroke in the Elderly (Posted in August 2015) Health reader for waiting room No.1 Gastritis, New Year's fatness, hay fever No.2 Hypertension / muscle pain / otitis media No.3 Dermatitis / athlete's foot / heat stroke No.4 Stress Insomnia / Pediatric Asthma / Influenza Takata Seiyaku's efforts are published in the Nihon Keizai Shimbun 1st (Posted on June 24, 2013) 2nd (Posted on August 9, 2013) 3rd (Posted on October 18, 2013) 4th (Posted on December 24, 2013) 6th (Posted on June 16, 2014) Our "generic drug" has three A's. We are TAKATA. Corporate information, factory information, etc. of Takata Seiyaku, a generic drug selected by trust. New graduate / mid-career recruitment information. Would you like to realize new life and ability development at Takata Seiyaku? A collection of links to medical institutions. Here are some frequently asked questions and answers in a Q & A. Takata Seiyaku pursues ease of use and ease of drinking. To maintain a healthy body, it is important to get along well with your medicine. We will inform you about the medicines that you will be prescribed by your doctor and the over-the-counter medicines that you can choose freely. Click here to see more about generics Reliable quality Stable supply Safety information Ingenuity of TAKATA pharmaceuticals Message from the President Management Philosophy Company Profile Factory information R & D activities Environmental Initiatives New graduate recruitment information Mid-career recruitment information Welfare Recruitment flow Inquiries about recruitment About generic drugs Generic drug Q & A Types of medicines and their roles Basic knowledge of taking medicine Ingenuity of TAKATA pharmaceuticals site map Contact Us Precautions for use privacy policy Link Collection Copyright © 2014 TAKATA Pharmaceutical Co., Ltd. All rights reserved.